of borderline significancep=0.053
The reduction in overall AF recurrence in the combined 500-mg and 750-mg groups was of borderline significance compared to the placebo group (p=0.053) and significant compared to 375-mg group (p=0.035).
The reduction in overall AF recurrence in the combined 500-mg and 750-mg groups was of borderline significance compared to the placebo group (p=0.053) and significant compared to 375-mg group (p=0.035).